Jones Soda Acquires UCAN Functional Nutrition Assets For About $1.2 Million

Jones Soda has completed the acquisition of substantially all operating assets associated with the UCAN functional nutrition brand through its Jones Labs business, expanding the company’s push into functional health and nutrition.

The transaction, which closed November 12, 2026, included approximately $700,000 in cash consideration and approximately $500,000 in assumed liabilities.

The assumed liabilities include roughly $400,000 in existing licensing fees payable in January 2027 and about $100,000 of other obligations. Approximately $200,000 of the January licensing obligation is expected to be satisfied through the issuance of Jones Soda common shares to Glycologic Limited at the market price at the time of issuance.

UCAN is a metabolic performance nutrition brand focused on sustained energy, endurance and active lifestyles. Its portfolio includes energy gels, nutrition bars, drink mixes, hydration products and protein nutrition products. Certain offerings incorporate LIVSTEADY carbohydrate technology.

Jones Soda plans to integrate UCAN’s products, brand, customer relationships and distribution channels into its existing infrastructure, processes and personnel.

The company expects the combination to create operational efficiencies while opening additional distribution opportunities across metabolic health, performance nutrition and everyday wellness markets.

Jones Soda also sees an opportunity to expand UCAN through its existing commercial infrastructure and customer relationships during 2027. UCAN’s direct-to-consumer operations are expected to increase the scale of Jones Soda’s existing DTC business, subject to successful integration.

Based on historical financial information supplied by the seller, UCAN-related operations generated approximately $4.9 million in net revenue and $1.9 million in gross profit during the nine months ended September 30, 2026, representing a gross margin of approximately 40%.

Full-year 2026 revenue for those operations had been projected at approximately $6 million before the acquisition.

Jones Soda said those historical figures relate to UCAN before the acquisition and are not guarantees of future results.

KEY QUOTE:

“The UCAN acquisition represents a tangible step forward in our functional health and nutrition strategy. We believe UCAN has significantly untapped growth potential by reaching consumers through new channels focused on metabolic health, performance nutrition and everyday wellness. Our priority is to identify and develop distribution opportunities that align with these consumer needs while leveraging Jones Soda’s infrastructure, operational capabilities and resources to support scalable growth and meaningful operating efficiencies. We expect to grow the UCAN business in 2027, leveraging our commercial infrastructure and customer relationships. We also expect UCAN’s direct-to-consumer activities to expand the scale of our existing DTC business, subject to successful integration.”

Scott Harvey, Chief Executive Officer Of Jones Soda